DJIA 16,461.32 -153.49 -0.92%
NASDAQ 4,382.85 -36.63 -0.83%
S&P 500 1,927.11 -14.17 -0.73%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

143.64 -0.45 (-0.31%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $143.64 -0.31%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $143.81
Previous Close $144.09
Daily Range $141.67 - $144.41
52-Week Range $108.20 - $145.49
Market Cap $109.1B
P/E Ratio 22.07
Dividend (Yield) $2.44 (1.7%)
Ex-Dividend Date
Dividend Pay Date
11/10/14
12/05/14
Volume 5,222,061
Average Daily Volume 3,951,750
Current FY EPS $8.24

Sector

Healthcare

Industry

Drugs

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary

Celgene Corporation's Earnings Preview: Pay Attention to New Kids

Revlimid might be the flagship, but growth will come from the newer drugs.

Amgen Gains as Third Point Suggests Split - Analyst Blog

Drug ETFs Attractive Buys On Pullback

Drug ETFs Attractive Buys On Pullback

Stock Market Today: Markets Tumble Into Close on Oil Inventory, Canadian Shooting

Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst B

Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst Blog

Despite Stock Market Rally Many Opportunities Still Exist

Daniel Loeb Comments on Amgen Inc

Third Point Q3 2014 Investor Letter

The Plan to Drive Amgen Shares Up Over 70%

See More AMGN News...

AMGN's Top Competitors

AMGN $143.64 (-0.31%)
Current stock: AMGN
GILD $106.09 (-0.54%)
Current stock: GILD
CELG $94.76 (-0.22%)
Current stock: CELG
$0.00 (0.00%)
Current stock: